Karachi: Liven Pharma Limited announced on July 15, 2026, a series of substantial share transactions executed by the company's Executive Director, Kaashif Hussain Siddique. These transactions were disclosed under the Pakistan Stock Exchange Regulation 5.6.4, which mandates transparency in the dealings of key company figures.
The transactions, conducted over several days in June and July 2026, involved the sale of shares in the company by Mr. Siddique. According to the announcement, the shares were traded within the ready market category. On June 15, 2026, Mr. Siddique sold a total of 25,000 shares in three separate transactions at varying rates, resulting in a cumulative holding of 48.96 million shares, representing 43.33% of the company's total shares.
The following day, June 16, saw the sale of an additional 10,000 shares, maintaining the cumulative percentage of shares held at 43.33%. On June 17, Mr. Siddique continued the sell-off with two transactions totaling 3,700 shares, followed by a further sale of 1,495 shares on June 18. The cumulative number of shares held after these transactions was reported at 48.95 million.
In a notable transaction on June 24, Mr. Siddique sold 9,375 shares, bringing the cumulative holding to 48.94 million shares. The most significant of these transactions occurred on July 6, when 30,000 shares were sold in two separate trades, reducing the cumulative number of shares held to 48.91 million, yet still maintaining the 43.33% ownership stake.
According to information available from the Pakistan Stock Exchange (PSX), these transactions reflect a strategic move by Mr. Siddique, aligning with regulatory requirements to disclose interests held by directors and substantial shareholders.
The pharmaceutical sector, where Liven Pharma operates, continues to be a focal point for market activities on the PSX. These transactions by a key executive are likely to draw attention from investors and market analysts, given their potential impact on shareholder confidence and the company's market valuation.